Effect of an Internet based compliance enhancement tool in subjects with hypercholesterolemia
Study identifier:D3560L00002
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Terminated/Withdrawn
Official Title
Open Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement of LDL Goals. - Denmark
Medical condition
Hypercholesterolemia
Phase
Phase 4
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1175
Study type
Interventional
Age
18 Years +
Date
Study Start Date: 01 Feb 2003
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Verification:
Verified 01 Mar 2009 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
AstraZeneca Denmark Medical Director
AstraZeneca A/S
